查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球基因組市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測
市場調查報告書
商品編碼
1342920

全球基因組市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測

Global Gene Panel Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 221 Pages | 商品交期: 最快1-2個工作天內

價格

全球基因檢測市場需求預計將從 2022 年的 32.9 億美元增至 2030 年的近 143.2 億美元，2023-2030 年研究期間年複合成長率為 20.2%。

基因檢測是一種診斷測試，用於在患者表現出可能由多種病症引起的症狀或多個基因的變異可能導致可疑病症時縮小診斷範圍。基因面板測試可以檢查大量基因，這有助於提供癌症資訊並提供安全的診斷以防止癌症擴散。基因組用於診斷和治療，例如癌症風險評估、症候群特異性診斷、疾病滲透和許多其他應用。

市場動態：

導致市場成長的重要因素是慢性病發病率和患病率的上升。此外，診斷服務的技術進步和醫療保健技術的現代化正在推動市場的成長。此外，不斷成長的持續研究和開發推動了基因面板市場的發展。此外，男性和女性癌症病例數量的增加以及基因組市場對抗癌症的好處推動了市場成長。然而，高昂的價格和個人對基因報告真實性的嚴重懷疑是基因面板市場成長的主要阻礙因素。此外，人們對基因檢測潛在益處的認知不斷增強，對先進醫學檢測的需求不斷增加，以及對針對性方法和個性化醫療的需求不斷成長，是全球基因檢測市場成長的主要驅動力。

該研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球基因組市場的每個細分市場進行了包容性評估。基因面板行業的成長和趨勢為這項研究提供了整體方法。

區域分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲基因面板市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。基因組市場的主要參與者包括Illumina, Inc.（美國）、BGI（中國）、Agilent Technologies（美國）、Eurofins Scientific（美國）、QIAGEN（德國）、GENEWIZ, Inc.（美國）、Novogene Corporation（中國） 、Personalis（美國）、Thermo Fisher Scientific（美國）、F. Hoffmann-La Roche AG（瑞士）、Integrated DNA Technologies (IDT)（美國）、GATC Biotech AG（GATC Biotech）（德國）和ArcherDx（我們）。本節包含競爭格局的整體視圖，包括各種戰略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第一章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：基因面板 - 行業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 行業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按產品和服務分類的市場吸引力分析
    • 按技術分類的市場吸引力分析
    • 設計的市場吸引力分析
    • 市場吸引力分析：按應用分類
    • 最終用戶的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷管道發展趨勢

第 5 章：COVID-19 爆發的影響分析

第 6 章：全球基因組市場分析：按產品和服務分類

  • 按產品和服務分類的概述
  • 歷史和預測數據
  • 按產品和服務分析
  • 測試套件
  • 測試服務

第 7 章：全球基因組市場分析：按技術

  • 按技術概述
  • 歷史和預測數據
  • 技術分析
  • 基於擴增子的方法
  • 基於雜交的方法

第 8 章：全球基因組市場分析：設計

  • 設計概述
  • 歷史和預測數據
  • 設計分析
  • 預先設計的基因面板
  • 客製化基因組合

第 9 章：全球基因組市場分析：按應用分類

  • 概述：按應用
  • 歷史和預測數據
  • 分析：按應用
  • 癌症風險評估（症候型、高外顯率、中高外顯率、綜合癌症風險、先天性疾病診斷）
  • 藥物遺傳學
  • 其他應用

第 10 章：全球基因組市場分析：按最終用戶分類

  • 最終用戶概述
  • 歷史和預測數據
  • 最終用戶分析
  • 研究及學術機構
  • 醫院和診斷實驗室
  • 製藥和生物技術公司

第 11 章：全球基因組市場分析：按地理位置

  • 頂級公司股票分析
  • 介紹
  • 北美銷售分析
    • 概述、歷史和預測銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家/地區銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概述、歷史和預測銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家/地區銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概述、歷史和預測銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區國家/地區銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳大利亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概述、歷史和預測銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家/地區銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概述、歷史和預測銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 12 章：基因面板公司的競爭格局

  • 基因組市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 13 章：公司簡介

  • 公司股份分析
  • 市場集中度
  • Illumina Inc. (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • BGI (China)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Agilent Technologies (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Eurofins Scientific (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • QIAGEN (Germany)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • GENEWIZ Inc. (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Novogene Corporation (China)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Personalis (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Thermo Fisher Scientific (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • F. Hoffmann-La Roche AG (SwitzerlAnd)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Integrated DNA Technologies (IDT) (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • GATC Biotech AG (GATC Biotech) (Germany)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • ArcherDx (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私營公司，則可能不包括在內

Product Code: VMR11219275

The global demand for Gene Panel Market is presumed to reach the market size of nearly USD 14.32 BN by 2030 from USD 3.29 BN in 2022 with a CAGR of 20.2% under the study period 2023 - 2030.

Gene panel is a diagnostic test used to narrow down a diagnosis when the patient shows symptoms that can be caused by a variety of conditions or when variants in multiple genes can cause the suspected condition. Gene panel tests can examine large numbers of genes which helps provide cancer information and provides a secure diagnosis to prevent cancer spread. Gene panel are used in diagnostics and treatments such as cancer risk assessment, syndrome-specific diagnostics, disease penetration, and many other applications.

MARKET DYNAMICS:

The significant factor attributing to the market's growth is the rising incidence and prevalence of chronic diseases. Moreover, increasing technological advancement in diagnostics services and modernization in healthcare techniques are driving the market's growth. Also, the growing ongoing research and development drive the gene panel market. Furthermore, the increasing number of cancer cases in males and females and the benefits of the gene panel market to fight cancer drive market growth. However, high prices and serious doubts among individuals about the authenticity of genetic reports are the major restraints of the gene panel market growth. In addition, growing awareness about the potential benefits of genetic testing, increasing demand for advanced medical testing, and rising demand for targeted approaches and personalized medicine are the primary drivers of the growth of the global gene panel market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of gene panel. The growth and trends of gene panel industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the gene panel market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product & Service

  • Test Kits
  • Testing Services

By Technique

  • Amplicon-Based Approach
  • Hybridization-Based Approach

By Design

  • Predesigned Gene Panel
  • Customized Gene Panel

By Application

  • Cancer Risk Assessment (Syndrome-Specific, High-Penetrance, High And Moderate-Penetrance, Comprehensive Cancer Risk, Diagnosis Of Congenital Diseases)
  • Pharmacogenetics
  • Other Applications

By End User

  • Research And Academic Institutes
  • Hospital And Diagnostic Laboratories
  • Pharmaceutical And Biotechnology Companies

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Gene Panel market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the gene panel market include Illumina, Inc. (US), BGI (China), Agilent Technologies (US), Eurofins Scientific (US), QIAGEN (Germany), GENEWIZ, Inc. (US), Novogene Corporation (China), Personalis (US), Thermo Fisher Scientific (US), F. Hoffmann-La Roche AG (Switzerland), Integrated DNA Technologies (IDT) (US), GATC Biotech AG (GATC Biotech) (Germany), and ArcherDx (US). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . GENE PANEL - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product & Service
    • 3.7.2 Market Attractiveness Analysis By Technique
    • 3.7.3 Market Attractiveness Analysis By Design
    • 3.7.4 Market Attractiveness Analysis By Application
    • 3.7.5 Market Attractiveness Analysis By End User
    • 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL GENE PANEL MARKET ANALYSIS BY PRODUCT & SERVICE

  • 6.1 Overview by Product & Service
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product & Service
  • 6.4 Test Kits Historic and Forecast Sales by Regions
  • 6.5 Testing Services Historic and Forecast Sales by Regions

7 . GLOBAL GENE PANEL MARKET ANALYSIS BY TECHNIQUE

  • 7.1 Overview by Technique
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Technique
  • 7.4 Amplicon-based Approach Historic and Forecast Sales by Regions
  • 7.5 Hybridization-based Approach Historic and Forecast Sales by Regions

8 . GLOBAL GENE PANEL MARKET ANALYSIS BY DESIGN

  • 8.1 Overview by Design
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Design
  • 8.4 Predesigned Gene Panel Historic and Forecast Sales by Regions
  • 8.5 Customized Gene Panel Historic and Forecast Sales by Regions

9 . GLOBAL GENE PANEL MARKET ANALYSIS BY APPLICATION

  • 9.1 Overview by Application
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Application
  • 9.4 Cancer Risk Assessment (Syndrome-specific, High-penetrance, High And Moderate-penetrance, Comprehensive Cancer Risk, Diagnosis Of Congenital Diseases) Historic and Forecast Sales by Regions
  • 9.5 Pharmacogenetics Historic and Forecast Sales by Regions
  • 9.6 Other Applications Historic and Forecast Sales by Regions

10 . GLOBAL GENE PANEL MARKET ANALYSIS BY END USER

  • 10.1 Overview by End User
  • 10.2 Historical and Forecast Data
  • 10.3 Analysis by End User
  • 10.4 Research And Academic Institutes Historic and Forecast Sales by Regions
  • 10.5 Hospital And Diagnostic Laboratories Historic and Forecast Sales by Regions
  • 10.6 Pharmaceutical And Biotechnology Companies Historic and Forecast Sales by Regions

11 . GLOBAL GENE PANEL MARKET ANALYSIS BY GEOGRAPHY

  • 11.1. Top Company Share Analysis
  • 11.2. Introduction
  • 11.3. North America Sales Analysis
    • 11.3.1. Overview, Historic and Forecast Sales Analysis
    • 11.3.2. North America By Segment Sales Analysis
    • 11.3.3. North America By Country Sales Analysis
    • 11.3.4. United State Sales Analysis
    • 11.3.5. Canada Sales Analysis
    • 11.3.6. Mexico Sales Analysis
  • 11.4. Europe Sales Analysis
    • 11.4.1. Overview, Historic and Forecast Sales Analysis
    • 11.4.2. Europe by Segment Sales Analysis
    • 11.4.3. Europe by Country Sales Analysis
    • 11.4.4. United Kingdom Sales Analysis
    • 11.4.5. France Sales Analysis
    • 11.4.6. Germany Sales Analysis
    • 11.4.7. Italy Sales Analysis
    • 11.4.8. Russia Sales Analysis
    • 11.4.9. Rest Of Europe Sales Analysis
  • 11.5. Asia Pacific Sales Analysis
    • 11.5.1. Overview, Historic and Forecast Sales Analysis
    • 11.5.2. Asia Pacific by Segment Sales Analysis
    • 11.5.3. Asia Pacific by Country Sales Analysis
    • 11.5.4. China Sales Analysis
    • 11.5.5. India Sales Analysis
    • 11.5.6. Japan Sales Analysis
    • 11.5.7. South Korea Sales Analysis
    • 11.5.8. Australia Sales Analysis
    • 11.5.9. Rest Of Asia Pacific Sales Analysis
  • 11.6. Latin America Sales Analysis
    • 11.6.1. Overview, Historic and Forecast Sales Analysis
    • 11.6.2. Latin America by Segment Sales Analysis
    • 11.6.3. Latin America by Country Sales Analysis
    • 11.6.4. Brazil Sales Analysis
    • 11.6.5. Argentina Sales Analysis
    • 11.6.6. Peru Sales Analysis
    • 11.6.7. Chile Sales Analysis
    • 11.6.8. Rest of Latin America Sales Analysis
  • 11.7. Middle East & Africa Sales Analysis
    • 11.7.1. Overview, Historic and Forecast Sales Analysis
    • 11.7.2. Middle East & Africa by Segment Sales Analysis
    • 11.7.3. Middle East & Africa by Country Sales Analysis
    • 11.7.4. Saudi Arabia Sales Analysis
    • 11.7.5. UAE Sales Analysis
    • 11.7.6. Israel Sales Analysis
    • 11.7.7. South Africa Sales Analysis
    • 11.7.8. Rest Of Middle East And Africa Sales Analysis

12 . COMPETITIVE LANDSCAPE OF THE GENE PANEL COMPANIES

  • 12.1. Gene Panel Market Competition
  • 12.2. Partnership/Collaboration/Agreement
  • 12.3. Merger And Acquisitions
  • 12.4. New Product Launch
  • 12.5. Other Developments

13 . COMPANY PROFILES OF GENE PANEL INDUSTRY

  • 13.1. Company Share Analysis
  • 13.2. Market Concentration Rate
  • 13.3. Illumina Inc. (US)
    • 13.3.1. Company Overview
    • 13.3.2. Company Revenue
    • 13.3.3. Products
    • 13.3.4. Recent Developments
  • 13.4. BGI (China)
    • 13.4.1. Company Overview
    • 13.4.2. Company Revenue
    • 13.4.3. Products
    • 13.4.4. Recent Developments
  • 13.5. Agilent Technologies (US)
    • 13.5.1. Company Overview
    • 13.5.2. Company Revenue
    • 13.5.3. Products
    • 13.5.4. Recent Developments
  • 13.6. Eurofins Scientific (US)
    • 13.6.1. Company Overview
    • 13.6.2. Company Revenue
    • 13.6.3. Products
    • 13.6.4. Recent Developments
  • 13.7. QIAGEN (Germany)
    • 13.7.1. Company Overview
    • 13.7.2. Company Revenue
    • 13.7.3. Products
    • 13.7.4. Recent Developments
  • 13.8. GENEWIZ Inc. (US)
    • 13.8.1. Company Overview
    • 13.8.2. Company Revenue
    • 13.8.3. Products
    • 13.8.4. Recent Developments
  • 13.9. Novogene Corporation (China)
    • 13.9.1. Company Overview
    • 13.9.2. Company Revenue
    • 13.9.3. Products
    • 13.9.4. Recent Developments
  • 13.10. Personalis (US)
    • 13.10.1. Company Overview
    • 13.10.2. Company Revenue
    • 13.10.3. Products
    • 13.10.4. Recent Developments
  • 13.11. Thermo Fisher Scientific (US)
    • 13.11.1. Company Overview
    • 13.11.2. Company Revenue
    • 13.11.3. Products
    • 13.11.4. Recent Developments
  • 13.12. F. Hoffmann-La Roche AG (SwitzerlAnd)
    • 13.12.1. Company Overview
    • 13.12.2. Company Revenue
    • 13.12.3. Products
    • 13.12.4. Recent Developments
  • 13.13. Integrated DNA Technologies (IDT) (US)
    • 13.13.1. Company Overview
    • 13.13.2. Company Revenue
    • 13.13.3. Products
    • 13.13.4. Recent Developments
  • 13.14. GATC Biotech AG (GATC Biotech) (Germany)
    • 13.14.1. Company Overview
    • 13.14.2. Company Revenue
    • 13.14.3. Products
    • 13.14.4. Recent Developments
  • 13.15. ArcherDx (US)
    • 13.15.1. Company Overview
    • 13.15.2. Company Revenue
    • 13.15.3. Products
    • 13.15.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product & Service (USD MN)
  • Test Kits Market Sales by Geography (USD MN)
  • Testing Services Market Sales by Geography (USD MN)
  • Analysis Market by Technique (USD MN)
  • Amplicon-based Approach Market Sales by Geography (USD MN)
  • Hybridization-based Approach Market Sales by Geography (USD MN)
  • Analysis by Design (USD MN)
  • Predesigned Gene Panel Market Sales by Geography (USD MN)
  • Customized Gene Panel Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Cancer Risk Assessment (Syndrome-specific, High-penetrance, High And Moderate-penetrance, Comprehensive Cancer Risk, Diagnosis Of Congenital Diseases) Market Sales by Geography (USD MN)
  • Pharmacogenetics Market Sales by Geography (USD MN)
  • Other Applications Market Sales by Geography (USD MN)
  • Analysis by End User (USD MN)
  • Research And Academic Institutes Market Sales by Geography (USD MN)
  • Hospital And Diagnostic Laboratories Market Sales by Geography (USD MN)
  • Pharmaceutical And Biotechnology Companies Market Sales by Geography (USD MN)
  • Global Gene Panel Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Gene Panel Report
  • Market Research Process
  • Market Research Methodology
  • Global Gene Panel Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product & Service
  • Market Attractiveness Analysis by Technique
  • Market Attractiveness Analysis by Design
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product & Service (USD MN)
  • Test Kits Market Sales by Geography (USD MN)
  • Testing Services Market Sales by Geography (USD MN)
  • Global Market Analysis by Technique (USD MN)
  • Amplicon-based Approach Market Sales by Geography (USD MN)
  • Hybridization-based Approach Market Sales by Geography (USD MN)
  • Global Market Analysis by Design (USD MN)
  • Predesigned Gene Panel Market Sales by Geography (USD MN)
  • Customized Gene Panel Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Cancer Risk Assessment (Syndrome-specific, High-penetrance, High And Moderate-penetrance, Comprehensive Cancer Risk, Diagnosis Of Congenital Diseases) Market Sales by Geography (USD MN)
  • Pharmacogenetics Market Sales by Geography (USD MN)
  • Other Applications Market Sales by Geography (USD MN)
  • Global Market Analysis by End User (USD MN)
  • Research And Academic Institutes Market Sales by Geography (USD MN)
  • Hospital And Diagnostic Laboratories Market Sales by Geography (USD MN)
  • Pharmaceutical And Biotechnology Companies Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.